HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Chang, Ming Ling ^a,b   Lin, Shi Ming ^a   Yeh, Chau Ting ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATOMA UPREGULATED PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG; DLGAP5 PROTEIN, HUMAN; TUMOR PROTEIN;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CYTOLOGY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CANCER; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; SCORING SYSTEM; TUMOR VOLUME; CLASSIFICATION; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 80054716869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026323     Document Type: Article

References (54)

1. Tsou AP, Yang CW, Huang CY, Yu RC, Lee YC, et al. (2003) Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma. Oncogene 22: 298-307.
2. Hsu JM, Lee YC, Yu CT, Huang CY, (2004) Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated HURP proteolysis by a proline-rich region. J Biol Chem 279: 32592-32602.
3. Carmena M, Earnshaw WC, (2003) The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 4: 842-854.
4. Wong J, Lerrigo R, Jang CY, Fang G, (2008) Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain. Mol Biol Cell 19: 2083-91.
5. Sanderson HS, Clarke PR, (2006) Cell biology: Ran, mitosis and the cancer connection. Curr Biol 16: R466-8.
6. Wilde A, (2006) "HURP on" we're off to the kinetochore! J Cell Biol 173: 829-31.
7. Davis TN, Wordeman L, (2007) Rings, bracelets, sleeves, and chevrons: new structures of kinetochore proteins. Trends Cell Biol 17: 377-82.
8. Wong J, Fang G, (2006) HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture. J Cell Biol 173: 879-91.
9. Wong J, Lerrigo R, Jang CY, Fang G, (2008) Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain. Mol Biol Cell 19: 2083-91.
10. Bischoff JR, Plowman GD, (1999) The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol 9: 454-459.
11. Tsai CY, Chou CK, Yang CW, Lai YC, Liang CC, et al. (2008) HURP deficiency in mice leads to female infertility caused by an implantation defect. J Biol Chem 283: 26302-6.
12. Chiu AW, Huang YL, Huan SK, et al. (2002) Potential molecular marker for detecting transitional cell carcinoma. Urology 60: 181-185.
13. Chiu AW, Huang YL, Huan SK, Wang YC, Ju JP, et al. (2003) Prognostic significance of hepatoma up-regulated protein expression in patients with urinary bladder transitional cell carcinoma. Anticancer Res 23: 2729-2734.
14. Betz MJ, Beuschlein F, (2009) Diagnosis: Novel molecular signatures for adrenocortical carcinoma. Nat Rev Endocrinol 5: 297-9.
15. de Reyniès A, Assié G, Rickman DS, Tissier F, Groussin L, et al. (2009) Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 27: 1108-15.
16. Yu CT, Hsu JM, Lee YC, Tsou AP, Chou CK, et al. (2005) Phosphorylation and stabilization of HURP by Aurora-A: implication of HURP as a transforming target of Aurora-A. Mol Cell Biol 25: 5789-800.
17. Wang YC, Lee YH, Huang GC, Lin YH, Fan-Chiang MH, et al. (2006) Enhanced transformation and chemosensitivity of NIH3T3 cells transduced with hepatoma up-regulated protein. Biochem Biophys Res Commun 340: 244-9.
18. Kuo TC, Chao CC, (2010) Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. Biochem Pharmacol 80: 1093-102.
19. Rustgi VK, (1987) Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 16: 545-551.
20. Talwalkar JA, Gores GJ, (2004) Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 127: S126-32.
21. El-Serag HB, Marrero JA, Rudolph L, Reddy KR, (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134: 1752-63.
22. Aravalli RN, Steer CJ, Cressman EN, (2008) Molecular mechanisms of hepatocellular carcinoma. Hepatology 48: 2047-63.
23. Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, et al. (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study. Hepatology 53: 136-47.
24. Noguchi S, Yamamoto R, Tatsuta M, Kasugai H, Okuda S, et al. (1986) Cell features and patterns in fine-needle aspirates of hepatocellular carcinoma. Cancer 58: 321-8.
25. Edmondson HA, Steiner PE, (1954) Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 7: 462-503.
26. Lin CC, Lin CJ, Hsu CW, Chen YC, Chen WT, et al. (2008) Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades. J Gastroenterol Hepatol 23: e146-52.
27. Chiu AW, Huang YL, Huan SK, Wang YC, Ju JP, et al. (2002) Potential molecular marker for detecting transitional cell carcinoma. Urology 60: 181-5.
28. Fernandes ML, Lin CC, Lin CJ, Chen WT, Lin SM, (2009) Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation. Br J Surg 96: 756-62.
29. Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, et al. (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228: 335-345.
30. Yeh CT, So M, Ng J, Yang HW, Chang ML, et al. (2010) Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology 52: 1922-33.
31. Mazumdar M, Glassman JR, (2000) Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med 19: 113-32.
32. Zhou Y, Zhao Y, Li B, Xu D, Yin Z, et al. (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 9;10: 78.
33. Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, et al. (2010) Radiofrequency Ablation Versus Surgical Resection for Hepatocellular Carcinoma in Childs A Cirrhotics-a Retrospective Study of 1,061 Cases. J Gastrointest Surg Oct 30.
34. Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, et al. (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study. Hepatology 53: 136-47.
35. Liu DQ, Lu MD, Tan JF, Wang Z, Zhou ZX, (2006) Microwave coagulation at different temperatures for hepatocellular carcinoma management: efficacy evaluation by enzyme histochemical staining. Nan Fang Yi Ke Da Xue Xue Bao 26: 1149-1151.
36. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243: 321-328.
37. Cho YK, Kim JK, Kim WT, Chung JW, (2010) Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 51: 1284-90.
38. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, et al. (2010) Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology 138: 493-502.
39. Gudmundsson KO, Thorsteinsson L, Sigurjonsson OE, Keller JR, Olafsson K, et al. (2007) Gene expression analysis of hematopoietic progenitor cells identifies Dlg7 as a potential stem cell gene. Stem Cells 25: 1498-506.
40. Murakata A, Tanaka S, Mogushi K, Yasen M, Noguchi N, et al. (2011) Gene expression signature of the gross morphology in hepatocellular carcinoma. Ann Surg 253: 94-100.
41. Portella G, Passaro C, Chieffi P (2010) Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer. Curr Med Chem Dec 14.
42. Lin ZZ, Jeng YM, Hu FC, Pan HW, Tsao HW, et al. (2010) Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC. BMC Cancer 10: 461.
43. Huang GT, Sheu JC, Yang PM, Lee HS, Wang TH, et al. (1996) Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma-A study based on 420 patients. J Hepatol 25: 334-338.
44. Nazir RT, Sharif MA, Iqbal M, Amin MS, (2010) Diagnostic accuracy of fine needle aspiration cytology in hepatic tumours. J Coll Physicians Surg Pak 20: 373-6.
45. Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, et al. (2011) Importin-α1 as a Novel Prognostic Target for Hepatocellular Carcinoma. Ann Surg Oncol Feb 1.
46. Lange A, Mills RE, Lange CJ, Stewart M, Devine SE, et al. (2007) Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem 282: 5101-5.
47. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, et al. (2005) Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100: 2708-16.
48. Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, et al. (2007) Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Ann Surg 245: 51-8.
49. Daniele B, Bencivenga A, Megna AS, Tinessa V, (2004) Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 127: S108-12.
50. Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY, et al. (2011) Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol 103: 148-51.
51. Fattovich G, Stroffolini T, Zagni I, Donato F, (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127: S35-50.
52. Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, et al. (2000) Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47: 131-136.
53. Komatsu S, Murakami M, Fukumoto T, Hori Y, Hishikawa Y, et al. (2011) Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma. Br J Surg Jan 19.
54. Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, et al. (2010) Radiofrequency Ablation Versus Surgical Resection for Hepatocellular Carcinoma in Childs A Cirrhotics-a Retrospective Study of 1,061 Cases. J Gastrointest Surg Oct 30.